Posts

Showing posts with the label Pharmaceuticals and Healthcare

Epidemiologists expect the diagnosed prevalent cases of BED in the 7MM to increase to 204,424 cases by 2027, at an CAGR of 0.37%

Image
Binge eating disorder (BED) is an eating disorder characterized by eating large quantities of food in a discrete period of time and feeling a sense of lack of control over eating during the episode. Signs of BED vary, and there may be physical changes; for example, some people experience weight gain.  Other signs and symptoms can be psychological and emotional. In May 2013, the American Psychiatric Association released the DSM-5 in which BED is classified as an actual eating disorder. In 2017, the 7MM had 197,076 diagnosed prevalent cases of BED. It epidemiologists expect the diagnosed prevalent cases of BED in the 7MM to increase to 204,424 cases by 2027, at an AGR of 0.37%. The US will have the highest growth in the diagnosed prevalent cases of BED in the 7MM from 2017-2027, while France will have the lowest growth in the diagnosed prevalent cases of BED from 2017-2027. Germany, Italy, and Japan will see a decline in the number of diagnosed ...

The stigma of mental disorders

Image
Our moods are not the same at every point in a day. We suffer grief, sometimes feel more elevated than ever, and sometimes are so pushed into our routine that we do not feel anything at all. Much of this can be said to be circumstance-based or is, in some cases, specifically caused due to hormonal fluctuations. But what if everyday things like the chatters we hear on crowded roads made you feel extremely uncomfortable? Or if you had to always live behind a locked door because you felt an irrational fear? If you could imagine this, you just stepped inside the shoe of a person affected by some form of a mental disorder. Healthcare marketresearch reports state that mental health is among the most extensively studied topics but is also the least understood in the current day. Victims of these syndromes or ailments are not restricted by age, locality or a lot of other factors that decide the occurrence of various diseases. Moreover, the entirety of the human brain’s circuitry is...

Human Parainfluenza Virus 3 Infections, H1 2018

Image
Human parainfluenza virus 3 is a life-threatening infection that causes respiratory illnesses in infants and young children. Symptoms include fever, cough, runny nose, croup, bronchiolitis, wheezing and sore throat. Treatment includes over-the-counter medications for pain and fever. Scope The pipeline guide provides a snapshot of the global therapeutic landscape of Human Parainfluenza Virus 3 Infections (Infectious Disease). The pipeline guide reviews pipeline therapeutics for Human Parainfluenza Virus 3 Infections (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources. The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. The pipeline guide features descriptive drug profiles for the pipeline products which compris...